{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T09:21:32Z","timestamp":1769505692244,"version":"3.49.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Scientific Research Foundation for Advanced Talents of Shanghai East Hospital","award":["DFRC2020003"],"award-info":[{"award-number":["DFRC2020003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"DOI":"10.1007\/s13402-025-01126-w","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:30:32Z","timestamp":1762867832000},"page":"2055-2072","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Elimination of docetaxel-induced senescence attenuates malignant progression in RB1-deficient CRPC"],"prefix":"10.1007","volume":"48","author":[{"given":"Huilan","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenwen","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean G.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guosheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"issue":"1","key":"1126_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"R.L. Siegel, A.N. Giaquinto, A. Jemal, Cancer statistics, 2024. CA Cancer J. Clin. 74(1), 12\u201349 (2024)","journal-title":"CA Cancer J. Clin."},{"key":"1126_CR2","doi-asserted-by":"crossref","unstructured":"S. Wasim, S.-Y. Lee, J. Kim, Complexities of prostate cancer. Int. J. Mol. Sci. 2022;23(22)","DOI":"10.3390\/ijms232214257"},{"key":"1126_CR3","doi-asserted-by":"publisher","first-page":"1410102","DOI":"10.3389\/fcell.2024.1410102","volume":"12","author":"H Su","year":"2024","unstructured":"H. Su, L. Huang, J. Zhou, G. Yang, Prostate cancer stem cells and their targeted therapies. Front. Cell. Dev. Biol. 12, 1410102 (2024)","journal-title":"Front. Cell. Dev. Biol."},{"issue":"722","key":"1126_CR4","doi-asserted-by":"publisher","first-page":"eadf6732","DOI":"10.1126\/scitranslmed.adf6732","volume":"15","author":"Y Yamada","year":"2023","unstructured":"Y. Yamada, V.B. Venkadakrishnan, K. Mizuno, M. Bakht, S.-Y. Ku, M.M. Garcia et al., Targeting DNA methylation and B7-H3 in RB1-deficient and neuroendocrine prostate cancer. Sci. Transl Med. 15(722), eadf6732 (2023)","journal-title":"Sci. Transl Med."},{"issue":"3","key":"1126_CR5","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nm.4045","volume":"22","author":"H Beltran","year":"2016","unstructured":"H. Beltran, D. Prandi, J.M. Mosquera, M. Benelli, L. Puca, J. Cyrta et al., Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. Nat. Med. 22(3), 298\u2013305 (2016)","journal-title":"Nat. Med."},{"key":"1126_CR6","unstructured":"D. A. Quigley, H.X. Dang, S.G. Zhao, P. Lloyd, R. Aggarwal, J.J. Alumkal et al., Genomic hallmarks and structural variation in metastatic prostate cancer. Cell. 174(3), (2018)"},{"issue":"5","key":"1126_CR7","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","volume":"161","author":"D Robinson","year":"2015","unstructured":"D. Robinson, Van E.M. Allen, Y.-M. Wu, N. Schultz, R.J. Lonigro, J.-M. Mosquera et al., Integrative clinical genomics of advanced prostate cancer. Cell. 161(5), 1215\u20131228 (2015)","journal-title":"Cell"},{"key":"1126_CR8","doi-asserted-by":"crossref","unstructured":"E.G. Bluemn, I.M. Coleman, J.M. Lucas, R.T. Coleman, S. Hernandez-Lopez, R. Tharakan et al., Androgen receptor Pathway-Independent prostate cancer is sustained through FGF signaling. Cancer Cell. 32(4), (2017)","DOI":"10.1016\/j.ccell.2017.09.003"},{"issue":"1","key":"1126_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","volume":"7","author":"RJ Rebello","year":"2021","unstructured":"R.J. Rebello, C. Oing, K.E. Knudsen, S. Loeb, D.C. Johnson, R.E. Reiter et al., Prostate cancer. Nat. Rev. Dis. Primers. 7(1), 9 (2021)","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"2","key":"1126_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2021.05.030","volume":"80","author":"S Sumanasuriya","year":"2021","unstructured":"S. Sumanasuriya, G. Seed, H. Parr, R. Christova, L. Pope, C. Bertan et al., Elucidating prostate cancer behaviour during treatment via Low-pass Whole-genome sequencing of Circulating tumour DNA. Eur. Urol. 80(2), 243\u2013253 (2021)","journal-title":"Eur. Urol."},{"issue":"1","key":"1126_CR11","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s13578-022-00941-0","volume":"12","author":"J Kallenbach","year":"2022","unstructured":"J. Kallenbach, G. Atri Roozbahani, M. Heidari Horestani, A. Baniahmad, Distinct mechanisms mediating therapy-induced cellular senescence in prostate cancer. Cell. Biosci. 12(1), 200 (2022)","journal-title":"Cell. Biosci."},{"issue":"2","key":"1126_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1158\/2159-8290.CD-16-0241","volume":"7","author":"M Demaria","year":"2017","unstructured":"M. Demaria, M.N. O\u2019Leary, J. Chang, L. Shao, S. Liu, F. Alimirah et al., Cellular senescence promotes adverse effects of chemotherapy and cancer relapse. Cancer Discov. 7(2), 165\u2013176 (2017)","journal-title":"Cancer Discov"},{"key":"1126_CR13","doi-asserted-by":"publisher","first-page":"7686","DOI":"10.1038\/nature25167","volume":"553","author":"M Milanovic","year":"2018","unstructured":"M. Milanovic, D.N.Y. Fan, D. Belenki, J.H.M. D\u00e4britz, Z. Zhao, Y. Yu et al., Senescence-associated reprogramming promotes cancer stemness. Nature. 553, 7686 (2018)","journal-title":"Nature"},{"issue":"2","key":"1126_CR14","doi-asserted-by":"publisher","first-page":"188424","DOI":"10.1016\/j.bbcan.2020.188424","volume":"1874","author":"VJ Carpenter","year":"2020","unstructured":"V.J. Carpenter, B.B. Patel, R. Autorino, S.C. Smith, D.A. Gewirtz, T. Saleh, Senescence and castration resistance in prostate cancer: A review of experimental evidence and clinical implications. Biochim. Biophys. Acta Rev. Cancer. 1874(2), 188424 (2020)","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"1126_CR15","doi-asserted-by":"crossref","unstructured":"I. Guccini, A. Revandkar, M. D\u2019Ambrosio, M. Colucci, E. Pasquini, S. Mosole et al., Senescence reprogramming by TIMP1 deficiency promotes prostate cancer metastasis. Cancer Cell. 39(1), (2021)","DOI":"10.1016\/j.ccell.2020.10.012"},{"issue":"7051","key":"1126_CR16","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/436642a","volume":"436","author":"M Collado","year":"2005","unstructured":"M. Collado, J. Gil, A. Efeyan, C. Guerra, A.J. Schuhmacher, M. Barradas et al., Tumour biology: senescence in premalignant tumours. Nature. 436(7051), 642 (2005)","journal-title":"Nature"},{"issue":"6","key":"1126_CR17","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1038\/s41418-019-0473-8","volume":"27","author":"F Guo","year":"2020","unstructured":"F. Guo, C. Zhang, F. Wang, W. Zhang, X. Shi, Y. Zhu et al., Deubiquitinating enzyme USP33 restrains docetaxel-induced apoptosis via stabilising the phosphatase DUSP1 in prostate cancer. Cell. Death Differ. 27(6), 1938\u20131951 (2020)","journal-title":"Cell. Death Differ."},{"issue":"11","key":"1126_CR18","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1158\/1535-7163.MCT-17-1296","volume":"17","author":"Y Zhang","year":"2018","unstructured":"Y. Zhang, Y. Dong, M.W. Melkus, S. Yin, S.-N. Tang, P. Jiang et al., Role of P53-Senescence induction in suppression of LNCaP prostate cancer growth by cardiotonic compound Bufalin. Mol. Cancer Ther. 17(11), 2341\u20132352 (2018)","journal-title":"Mol. Cancer Ther."},{"issue":"5","key":"1126_CR19","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10059-009-0141-9","volume":"28","author":"J-Y Kang","year":"2009","unstructured":"J.-Y. Kang, J.J. Kim, S.Y. Jang, Y.-S. Bae, The p53-p21(Cip1\/WAF1) pathway is necessary for cellular senescence induced by the Inhibition of protein kinase CKII in human colon cancer cells. Mol. Cells. 28(5), 489\u2013494 (2009)","journal-title":"Mol. Cells"},{"issue":"12","key":"1126_CR20","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.devcel.2023.05.010","volume":"58","author":"M D\u2019Ambrosio","year":"2023","unstructured":"M. D\u2019Ambrosio, J. Gil, Reshaping of the tumor microenvironment by cellular senescence: an opportunity for senotherapies. Dev. Cell. 58(12), 1007\u20131021 (2023)","journal-title":"Dev. Cell."},{"issue":"11","key":"1126_CR21","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.trecan.2016.10.001","volume":"2","author":"SG Rao","year":"2016","unstructured":"S.G. Rao, J.G. Jackson, SASP: tumor suppressor or promoter? Yes! Trends Cancer. 2(11), 676\u2013687 (2016)","journal-title":"Trends Cancer"},{"issue":"1","key":"1126_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.celrep.2014.08.044","volume":"9","author":"A Toso","year":"2014","unstructured":"A. Toso, A. Revandkar, Di D. Mitri, I. Guccini, M. Proietti, M. Sarti et al., Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity. Cell. Rep. 9(1), 75\u201389 (2014)","journal-title":"Cell. Rep."},{"issue":"4","key":"1126_CR23","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1189\/jlb.0108024","volume":"84","author":"NJ Maciver","year":"2008","unstructured":"N.J. Maciver, S.R. Jacobs, H.L. Wieman, J.A. Wofford, J.L. Coloff, J.C. Rathmell, Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J. Leukoc. Biol. 84(4), 949\u2013957 (2008)","journal-title":"J. Leukoc. Biol."},{"issue":"7","key":"1126_CR24","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nrm3823","volume":"15","author":"D Mu\u00f1oz-Esp\u00edn","year":"2014","unstructured":"D. Mu\u00f1oz-Esp\u00edn, M. Serrano, Cellular senescence: from physiology to pathology. Nat. Rev. Mol. Cell. Biol. 15(7), 482\u2013496 (2014)","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"1126_CR25","doi-asserted-by":"crossref","unstructured":"J. Behmoaras, J. Gil, Similarities and interplay between senescent cells and macrophages. J. Cell. Biol. 220(2), (2021)","DOI":"10.1083\/jcb.202010162"},{"key":"1126_CR26","doi-asserted-by":"publisher","first-page":"114765","DOI":"10.1016\/j.bcp.2021.114765","volume":"193","author":"V Carpenter","year":"2021","unstructured":"V. Carpenter, T. Saleh, S. Min Lee, G. Murray, J. Reed, A. Souers et al., Androgen-deprivation induced senescence in prostate cancer cells is permissive for the development of castration-resistance but susceptible to senolytic therapy. Biochem. Pharmacol. 193, 114765 (2021)","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"1126_CR27","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/nrc2696","volume":"9","author":"H-Z Chen","year":"2009","unstructured":"H.-Z. Chen, S.-Y. Tsai, G. Leone, Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat. Rev. Cancer. 9(11), 785\u2013797 (2009)","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"1126_CR28","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41419-024-06916-y","volume":"15","author":"S Bhattacharya","year":"2024","unstructured":"S. Bhattacharya, H.L. Harris, R. Islam, S. Bodas, N. Polavaram, J. Mishra et al., Understanding the function of Pax5 in development of docetaxel-resistant neuroendocrine-like prostate cancers. Cell. Death Dis. 15(8), 617 (2024)","journal-title":"Cell. Death Dis."},{"issue":"6320","key":"1126_CR29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.aah4307","volume":"355","author":"P Mu","year":"2017","unstructured":"P. Mu, Z. Zhang, M. Benelli, W.R. Karthaus, E. Hoover, C.-C. Chen et al., SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer. Science. 355(6320), 84\u201388 (2017)","journal-title":"Science"},{"issue":"1","key":"1126_CR30","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41420-021-00634-6","volume":"7","author":"W Zhu","year":"2021","unstructured":"W. Zhu, X. Zhang, M. Yu, B. Lin, C. Yu, Radiation-induced liver injury and hepatocyte senescence. Cell. Death Discov. 7(1), 244 (2021)","journal-title":"Cell. Death Discov"},{"issue":"1","key":"1126_CR31","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1038\/s41467-025-57229-3","volume":"16","author":"KN Miller","year":"2025","unstructured":"K.N. Miller, B. Li, H.R. Pierce-Hoffman, S. Patel, X. Lei, A. Rajesh et al., p53 enhances DNA repair and suppresses cytoplasmic chromatin fragments and inflammation in senescent cells. Nat. Commun. 16(1), 2229 (2025)","journal-title":"Nat. Commun."},{"issue":"1","key":"1126_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00726-020-02925-1","volume":"53","author":"P Torricelli","year":"2021","unstructured":"P. Torricelli, A.C. Elia, G. Magara, G. Feriotto, C. Forni, I. Borromeo et al., Reduction of oxidative stress and ornithine decarboxylase expression in a human prostate cancer cell line PC-3 by a combined treatment with \u03b1-tocopherol and naringenin. Amino Acids. 53(1), 63\u201372 (2021)","journal-title":"Amino Acids"},{"key":"1126_CR33","doi-asserted-by":"publisher","first-page":"2108584","DOI":"10.1155\/2023\/2108584","volume":"2023","author":"R Zou","year":"2023","unstructured":"R. Zou, S. Wang, H. Cai, Y. Wang, C. Wang, Pharmacological activation of Rev-erb\u03b1 attenuates Doxorubicin-Induced cardiotoxicity by PGC-1\u03b1 signaling pathway. Cardiovasc. Ther. 2023, 2108584 (2023)","journal-title":"Cardiovasc. Ther."},{"issue":"1","key":"1126_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12931-020-1275-8","volume":"21","author":"K Krempaska","year":"2020","unstructured":"K. Krempaska, S. Barnowski, J. Gavini, N. Hobi, S. Ebener, C. Simillion et al., Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls [corrected]. Respir Res. 21(1), 25 (2020)","journal-title":"Respir Res."},{"key":"1126_CR35","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2147\/OTT.S228453","volume":"13","author":"X Zhang","year":"2020","unstructured":"X. Zhang, J. Huang, C. Yu, L. Xiang, L. Li, D. Shi et al., Quercetin enhanced Paclitaxel therapeutic effects towards PC-3 prostate cancer through ER stress induction and ROS production. Onco Targets Ther. 13, 513\u2013523 (2020)","journal-title":"Onco Targets Ther."},{"issue":"10","key":"1126_CR36","doi-asserted-by":"publisher","first-page":"e0139871","DOI":"10.1371\/journal.pone.0139871","volume":"10","author":"Y-H Hsu","year":"2015","unstructured":"Y.-H. Hsu, C.-Y. Wu, C.-H. Hsing, W.-T. Lai, L.-W. Wu, M.-S. Chang, Anti-IL-20 monoclonal antibody suppresses prostate cancer growth and bone osteolysis in murine models. PLoS One. 10(10), e0139871 (2015)","journal-title":"PLoS One"},{"issue":"4","key":"1126_CR37","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/ijc.29835","volume":"138","author":"L Meder","year":"2016","unstructured":"L. Meder, K. K\u00f6nig, L. Ozreti\u0107, A.M. Schultheis, F. Ueckeroth, C.P. Ade et al., NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas. Int. J. Cancer. 138(4), 927\u2013938 (2016)","journal-title":"Int. J. Cancer"},{"issue":"28","key":"1126_CR38","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1200\/JCO.2016.72.1068","volume":"35","author":"S Oudard","year":"2017","unstructured":"S. Oudard, K. Fizazi, L. Sengel\u00f8v, G. Daugaard, F. Saad, S. Hansen et al., Cabazitaxel versus docetaxel as First-Line therapy for patients with metastatic Castration-Resistant prostate cancer: A randomized phase III Trial-FIRSTANA. J. Clin. Oncol. 35(28), 3189\u20133197 (2017)","journal-title":"J. Clin. Oncol."},{"issue":"15","key":"1126_CR39","first-page":"3761","volume":"59","author":"BD Chang","year":"1999","unstructured":"B.D. Chang, E.V. Broude, M. Dokmanovic, H. Zhu, A. Ruth, Y. Xuan et al., A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res. 59(15), 3761\u20133767 (1999)","journal-title":"Cancer Res."},{"issue":"9","key":"1126_CR40","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1593\/neo.05250","volume":"7","author":"SR Schwarze","year":"2005","unstructured":"S.R. Schwarze, V.X. Fu, J.A. Desotelle, M.L. Kenowski, D.F. Jarrard, The identification of senescence-specific genes during the induction of senescence in prostate cancer cells. Neoplasia. 7(9), 816\u2013823 (2005)","journal-title":"Neoplasia"},{"key":"1126_CR41","doi-asserted-by":"crossref","unstructured":"N. Bancaro, B. Cal\u00ec, M. Troiani, A.R. Elia, R.A. Arzola, G. Attanasio et al., Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancer. Cancer Cell. 41(3), (2023)","DOI":"10.1016\/j.ccell.2023.02.004"},{"issue":"10","key":"1126_CR42","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1038\/s43587-023-00480-4","volume":"3","author":"C Anerillas","year":"2023","unstructured":"C. Anerillas, K. Mazan-Mamczarz, A.B. Herman, R. Munk, K.-W.G. Lam, M. Calvo-Rubio et al., The YAP-TEAD complex promotes senescent cell survival by Lowering Endoplasmic reticulum stress. Nat. Aging. 3(10), 1237\u20131250 (2023)","journal-title":"Nat. Aging"},{"key":"1126_CR43","doi-asserted-by":"publisher","first-page":"14728","DOI":"10.1038\/ncomms14728","volume":"8","author":"AR Barr","year":"2017","unstructured":"A.R. Barr, S. Cooper, F.S. Heldt, F. Butera, H. Stoy, J. Mansfeld et al., DNA damage during S-phase mediates the proliferation-quiescence decision in the subsequent G1 via p21 expression. Nat. Commun. 8, 14728 (2017)","journal-title":"Nat. Commun."},{"issue":"3","key":"1126_CR44","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.molcel.2007.06.013","volume":"27","author":"V Amador","year":"2007","unstructured":"V. Amador, S. Ge, P.G. Santamar\u00eda, D. Guardavaccaro, M. Pagano, APC\/C(Cdc20) controls the ubiquitin-mediated degradation of p21 in prometaphase. Mol. Cell. 27(3), 462\u2013473 (2007)","journal-title":"Mol. Cell."},{"issue":"1","key":"1126_CR45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1046\/j.1365-313x.2002.01196.x","volume":"29","author":"S Kosugi","year":"2002","unstructured":"S. Kosugi, Y. Ohashi, E2F sites that can interact with E2F proteins cloned from rice are required for meristematic tissue-specific expression of rice and tobacco proliferating cell nuclear antigen promoters. Plant. J. 29(1), 45\u201359 (2002)","journal-title":"Plant. J."},{"issue":"28","key":"1126_CR46","doi-asserted-by":"publisher","first-page":"25752","DOI":"10.1074\/jbc.M301774200","volume":"278","author":"G Bornstein","year":"2003","unstructured":"G. Bornstein, J. Bloom, D. Sitry-Shevah, K. Nakayama, M. Pagano, A. Hershko, Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase. J. Biol. Chem. 278(28), 25752\u201325757 (2003)","journal-title":"J. Biol. Chem."},{"issue":"21","key":"1126_CR47","doi-asserted-by":"publisher","first-page":"15462","DOI":"10.1074\/jbc.M610758200","volume":"282","author":"S Xu","year":"2007","unstructured":"S. Xu, M. Abbasian, P. Patel, K. Jensen-Pergakes, C.R. Lombardo, B.E. Cathers et al., Substrate recognition and ubiquitination of SCFSkp2\/Cks1 ubiquitin-protein isopeptide ligase. J. Biol. Chem. 282(21), 15462\u201315470 (2007)","journal-title":"J. Biol. Chem."},{"key":"1126_CR48","doi-asserted-by":"crossref","unstructured":"L. Yuan, Q. Chen, J.E. Riviere, Z. Lin, Pharmacokinetics and tumor delivery of nanoparticles. J. Drug Deliv Sci. Technol. 2023;83","DOI":"10.1016\/j.jddst.2023.104404"},{"issue":"15","key":"1126_CR49","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1056\/NEJMoa041318","volume":"351","author":"DP Petrylak","year":"2004","unstructured":"D.P. Petrylak, C.M. Tangen, M.H.A. Hussain, P.N. Lara, J.A. Jones, M.E. Taplin et al., Docetaxel and Estramustine compared with Mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl. J. Med. 351(15), 1513\u20131520 (2004)","journal-title":"N Engl. J. Med."},{"issue":"1","key":"1126_CR50","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13578-022-00815-5","volume":"12","author":"Y Sun","year":"2022","unstructured":"Y. Sun, X. Wang, T. Liu, X. Zhu, X. Pan, The multifaceted role of the SASP in atherosclerosis: from mechanisms to therapeutic opportunities. Cell. Biosci. 12(1), 74 (2022)","journal-title":"Cell. Biosci."},{"key":"1126_CR51","doi-asserted-by":"crossref","unstructured":"J. Giroud, I. Bouriez, H. Paulus, A. Pourtier, F. Debacq-Chainiaux, O. Pluquet, Exploring the communication of the SASP: Dynamic, Interactive, and adaptive effects on the microenvironment. Int. J. Mol. Sci. 24(13), (2023)","DOI":"10.3390\/ijms241310788"},{"issue":"1","key":"1126_CR52","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41420-024-02048-6","volume":"10","author":"RN Taylor","year":"2024","unstructured":"R.N. Taylor, S.L. Berga, E. Zou, J. Washington, S. Song, B.J. Marzullo et al., Interleukin-1\u03b2 induces and accelerates human endometrial stromal cell senescence and impairs decidualization via the c-Jun N-terminal kinase pathway. Cell. Death Discov. 10(1), 288 (2024)","journal-title":"Cell. Death Discov"},{"key":"1126_CR53","doi-asserted-by":"publisher","first-page":"102314","DOI":"10.1016\/j.arr.2024.102314","volume":"97","author":"EE Saad","year":"2024","unstructured":"E.E. Saad, R. Michel, M.A. Borahay, Senescence-associated secretory phenotype (SASP) and uterine fibroids: association with PD-L1 activation and collagen deposition. Ageing Res. Rev. 97, 102314 (2024)","journal-title":"Ageing Res. Rev."},{"key":"1126_CR54","doi-asserted-by":"crossref","unstructured":"C.M. Carver, S.L. Rodriguez, E.J. Atkinson, A.J. Dosch, N.C. Asmussen, P.T. Gomez et al., IL-23R is a senescence-linked Circulating and tissue biomarker of aging. Nat. Aging (2024)","DOI":"10.1038\/s43587-024-00752-7"},{"issue":"12","key":"1126_CR55","doi-asserted-by":"publisher","first-page":"5690","DOI":"10.1002\/ptr.8343","volume":"38","author":"P Chen","year":"2024","unstructured":"P. Chen, Z. Zhang, J. Lei, J. Zhu, G. Liu, Ellagitannin component Punicalin ameliorates cognitive Dysfunction, oxidative Stress, and neuroinflammation via the Inhibition of cGAS-STING signaling in the brain of an aging mouse model. Phytother Res. 38(12), 5690\u20135712 (2024)","journal-title":"Phytother Res."},{"issue":"6720","key":"1126_CR56","doi-asserted-by":"publisher","first-page":"eadn0327","DOI":"10.1126\/science.adn0327","volume":"386","author":"MD Park","year":"2024","unstructured":"M.D. Park, Le J. Berichel, P. Hamon, C.M. Wilk, M. Belabed, N. Yatim et al., Hematopoietic aging promotes cancer by fueling IL-1\u237a-driven emergency myelopoiesis. Science. 386(6720), eadn0327 (2024)","journal-title":"Science"},{"issue":"1","key":"1126_CR57","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1677\/ERC-08-0174","volume":"16","author":"K Malinowska","year":"2009","unstructured":"K. Malinowska, H. Neuwirt, I.T. Cavarretta, J. Bektic, H. Steiner, H. Dietrich et al., Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor. Endocr. Relat. Cancer. 16(1), 155\u2013169 (2009)","journal-title":"Endocr. Relat. Cancer"},{"issue":"6","key":"1126_CR58","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1093\/carcin\/bgn109","volume":"29","author":"A Seaton","year":"2008","unstructured":"A. Seaton, P. Scullin, P.J. Maxwell, C. Wilson, J. Pettigrew, R. Gallagher et al., Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation. Carcinogenesis. 29(6), 1148\u20131156 (2008)","journal-title":"Carcinogenesis"},{"key":"1126_CR59","doi-asserted-by":"publisher","first-page":"116738","DOI":"10.1016\/j.ecoenv.2024.116738","volume":"282","author":"SH Seong","year":"2024","unstructured":"S.H. Seong, J.Y. Kim, S.H. Kim, J. Lee, E.J. Lee, Y.J. Bae et al., Interleukin-24: A molecular mediator of particulate matter\u2019s impact on skin aging. Ecotoxicol. Environ. Saf. 282, 116738 (2024)","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"1","key":"1126_CR60","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12929-018-0439-z","volume":"25","author":"H-H Wang","year":"2018","unstructured":"H.-H. Wang, Y.-H. Hsu, M.-S. Chang, IL-20 bone diseases involvement and therapeutic target potential. J. Biomed. Sci. 25(1), 38 (2018)","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"1126_CR61","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41368-021-00116-6","volume":"13","author":"Q Wang","year":"2021","unstructured":"Q. Wang, L. Nie, P. Zhao, X. Zhou, Y. Ding, Q. Chen et al., Diabetes fuels periodontal lesions via GLUT1-driven macrophage inflammaging. Int. J. Oral Sci. 13(1), 11 (2021)","journal-title":"Int. J. Oral Sci."},{"key":"1126_CR62","doi-asserted-by":"publisher","first-page":"1209249","DOI":"10.3389\/fimmu.2023.1209249","volume":"14","author":"S Gunalp","year":"2023","unstructured":"S. Gunalp, D.G. Helvaci, A. Oner, A. Bursal\u0131, A. Conforte, H. G\u00fcner et al., TRAIL promotes the polarization of human macrophages toward a Proinflammatory M1 phenotype and is associated with increased survival in cancer patients with high tumor macrophage content. Front. Immunol. 14, 1209249 (2023)","journal-title":"Front. Immunol."},{"key":"1126_CR63","doi-asserted-by":"publisher","first-page":"123204","DOI":"10.1016\/j.jhazmat.2020.123204","volume":"400","author":"H Su","year":"2020","unstructured":"H. Su, G. Guan, R.Z. Ahmed, L. Lyu, Z. Li, X. Jin, TBBPA stimulated cell migration of endometrial cancer via the contribution of NOX-generated ROS in lieu of energy metabolism. J. Hazard. Mater. 400, 123204 (2020)","journal-title":"J. Hazard. Mater."},{"issue":"4","key":"1126_CR64","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/s41418-020-00650-6","volume":"28","author":"L-Z Rao","year":"2021","unstructured":"L.-Z. Rao, Y. Wang, L. Zhang, G. Wu, L. Zhang, F.-X. Wang et al., IL-24 deficiency protects mice against bleomycin-induced pulmonary fibrosis by repressing IL-4-induced M2 program in macrophages. Cell. Death Differ. 28(4), 1270\u20131283 (2021)","journal-title":"Cell. Death Differ."},{"issue":"3","key":"1126_CR65","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4103\/aja202259","volume":"25","author":"H-Y Dong","year":"2023","unstructured":"H.-Y. Dong, L. Ding, T.-R. Zhou, T. Yan, J. Li, C. Liang, FOXA1 in prostate cancer. Asian J. Androl. 25(3), 287\u2013295 (2023)","journal-title":"Asian J. Androl."},{"issue":"1","key":"1126_CR66","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41698-024-00713-8","volume":"8","author":"ML Ludwig","year":"2024","unstructured":"M.L. Ludwig, D. Moline, A. Horrmann, E. Boytim, G. Larson, A.T. Arafa et al., Integrated multi-omics assessment of lineage plasticity in a prostate cancer patient with brain and dural metastases. NPJ Precis Oncol. 8(1), 215 (2024)","journal-title":"NPJ Precis Oncol."},{"issue":"6","key":"1126_CR67","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.juro.2018.06.031","volume":"200","author":"KA Richards","year":"2018","unstructured":"K.A. Richards, J.-I. Liou, V.L. Cryns, T.M. Downs, E.J. Abel, D.F. Jarrard, Metformin use is associated with improved survival for patients with advanced prostate cancer on androgen deprivation therapy. J. Urol. 200(6), 1256\u20131263 (2018)","journal-title":"J. Urol."},{"issue":"11","key":"1126_CR68","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.18632\/aging.101100","volume":"8","author":"Y Wang","year":"2016","unstructured":"Y. Wang, J. Chang, X. Liu, X. Zhang, S. Zhang, X. Zhang et al., Discovery of Piperlongumine as a potential novel lead for the development of senolytic agents. Aging (Albany NY). 8(11), 2915\u20132926 (2016)","journal-title":"Aging (Albany NY)"},{"key":"1126_CR69","doi-asserted-by":"publisher","first-page":"116385","DOI":"10.1016\/j.bcp.2024.116385","volume":"226","author":"V Carpenter","year":"2024","unstructured":"V. Carpenter, T. Saleh, E. Chakraborty, S. Min Lee, G. Murray, J. Reed et al., Androgen deprivation-induced senescence confers sensitivity to a senolytic strategy in prostate cancer. Biochem. Pharmacol. 226, 116385 (2024)","journal-title":"Biochem. Pharmacol."},{"issue":"23","key":"1126_CR70","doi-asserted-by":"publisher","first-page":"5935","DOI":"10.1158\/0008-5472.CAN-21-0752","volume":"81","author":"E Fletcher-Sananikone","year":"2021","unstructured":"E. Fletcher-Sananikone, S. Kanji, N. Tomimatsu, Di L.F.M. Cristofaro, R.K. Kollipara, D. Saha et al., Elimination of Radiation-Induced senescence in the brain tumor microenvironment attenuates glioblastoma recurrence. Cancer Res. 81(23), 5935\u20135947 (2021)","journal-title":"Cancer Res."},{"issue":"7884","key":"1126_CR71","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-021-03995-1","volume":"599","author":"S Lee","year":"2021","unstructured":"S. Lee, Y. Yu, J. Trimpert, F. Benthani, M. Mairhofer, P. Richter-Pechanska et al., Virus-induced senescence is a driver and therapeutic target in COVID-19. Nature. 599(7884), 283\u2013289 (2021)","journal-title":"Nature"},{"key":"1126_CR72","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.actbio.2024.01.002","volume":"176","author":"B Escriche-Navarro","year":"2024","unstructured":"B. Escriche-Navarro, E. Garrido, F. Sancen\u00f3n, A. Garc\u00eda-Fern\u00e1ndez, R. Mart\u00ednez-M\u00e1\u00f1ez, A navitoclax-loaded nanodevice targeting matrix metalloproteinase-3 for the selective elimination of senescent cells. Acta Biomater. 176, 405\u2013416 (2024)","journal-title":"Acta Biomater."},{"key":"1126_CR73","doi-asserted-by":"crossref","unstructured":"P. Torres, C. Anerillas, O. Ram\u00edrez-N\u00fa\u00f1ez, A. Fern\u00e0ndez, M. Encinas, M. Povedano et al., A motor neuron disease mouse model reveals a non-canonical profile of senescence biomarkers. Dis. Model. Mech. 15(8), (2022)","DOI":"10.1242\/dmm.049059"},{"key":"1126_CR74","doi-asserted-by":"crossref","unstructured":"K. Kumar, B.-H. Moon, S. Kumar, J. Angdisen, B.V.S. Kallakury, A.J. Fornace et al., Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer development in Apc1638N\/+ mice. Aging (Albany NY). 16, (2025)","DOI":"10.18632\/aging.206183"},{"issue":"7","key":"1126_CR75","first-page":"3739","volume":"34","author":"H Xiong","year":"2014","unstructured":"H. Xiong, R.S. Pradhan, A. Nada, A.P. Krivoshik, K.D. Holen, J.W. Rhodes et al., Studying navitoclax, a targeted anticancer drug, in healthy volunteers\u2013ethical considerations and risk\/benefit assessments and management. Anticancer Res. 34(7), 3739\u20133746 (2014)","journal-title":"Anticancer Res."},{"issue":"12","key":"1126_CR76","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1038\/s41591-019-0668-z","volume":"25","author":"S Khan","year":"2019","unstructured":"S. Khan, X. Zhang, D. Lv, Q. Zhang, Y. He, P. Zhang et al., A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity. Nat. Med. 25(12), 1938\u20131947 (2019)","journal-title":"Nat. Med."},{"key":"1126_CR77","doi-asserted-by":"crossref","unstructured":"J. Bas, T. Nguyen, G. Gillet, Involvement of Bcl-xL in neuronal function and development. Int. J. Mol. Sci. 22(6), (2021)","DOI":"10.3390\/ijms22063202"},{"issue":"1","key":"1126_CR78","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/cdd.2017.186","volume":"25","author":"J Kale","year":"2018","unstructured":"J. Kale, E.J. Osterlund, D.W. Andrews, BCL-2 family proteins: changing partners in the dance towards death. Cell. Death Differ. 25(1), 65\u201380 (2018)","journal-title":"Cell. Death Differ."},{"key":"1126_CR79","doi-asserted-by":"crossref","unstructured":"S. Bhatt, M.S. Pioso, E.A. Olesinski, B. Yilma, J.A. Ryan, T. Mashaka et al., Reduced mitochondrial apoptotic priming drives resistance to BH3 mimetics in acute myeloid leukemia. Cancer Cell. 38(6), (2020)","DOI":"10.1016\/j.ccell.2020.10.010"},{"issue":"12","key":"1126_CR80","doi-asserted-by":"publisher","first-page":"e202100689","DOI":"10.1002\/cbic.202100689","volume":"23","author":"A Negi","year":"2022","unstructured":"A. Negi, A.S. Voisin-Chiret, Strategies to reduce the On-Target platelet toxicity of Bcl-xL inhibitors: PROTACs, snipers and Prodrug-Based approaches. Chembiochem. 23(12), e202100689 (2022)","journal-title":"Chembiochem"},{"key":"1126_CR81","doi-asserted-by":"crossref","unstructured":"Z. Wang, B.-S. Pan, R.K. Manne, J. Chen, D. Lv, M. Wang et al., CD36-mediated endocytosis of proteolysis-targeting chimeras. Cell 188(12), (2025)","DOI":"10.1016\/j.cell.2025.03.036"},{"issue":"12","key":"1126_CR82","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1038\/s41418-021-00816-w","volume":"28","author":"P Ramesh","year":"2021","unstructured":"P. Ramesh, T.R.M. Lannagan, R. Jackstadt, L. Atencia Taboada, N. Lansu, P. Wirapati et al., BCL-XL is crucial for progression through the adenoma-to-carcinoma sequence of colorectal cancer. Cell. Death Differ. 28(12), 3282\u20133296 (2021)","journal-title":"Cell. Death Differ."},{"issue":"6","key":"1126_CR83","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1158\/2159-8290.CD-20-1465","volume":"11","author":"VA Pullarkat","year":"2021","unstructured":"V.A. Pullarkat, N.J. Lacayo, E. Jabbour, J.E. Rubnitz, A. Bajel, T.W. Laetsch et al., Venetoclax and navitoclax in combination with chemotherapy in patients with relapsed or refractory acute lymphoblastic leukemia and lymphoblastic lymphoma. Cancer Discov. 11(6), 1440\u20131453 (2021)","journal-title":"Cancer Discov"},{"issue":"4","key":"1126_CR84","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41418-024-01283-9","volume":"31","author":"J Jia","year":"2024","unstructured":"J. Jia, W. Ji, A.N. Saliba, C.M. Csizmar, K. Ye, L. Hu et al., AMPK Inhibition sensitizes acute leukemia cells to BH3 mimetic-induced cell death. Cell. Death Differ. 31(4), 405\u2013416 (2024)","journal-title":"Cell. Death Differ."},{"issue":"12","key":"1126_CR85","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/S1470-2045(10)70261-8","volume":"11","author":"WH Wilson","year":"2010","unstructured":"W.H. Wilson, O.A. O\u2019Connor, M.S. Czuczman, A.S. LaCasce, J.F. Gerecitano, J.P. Leonard et al., Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity. Lancet Oncol. 11(12), 1149\u20131159 (2010)","journal-title":"Lancet Oncol."},{"issue":"7","key":"1126_CR86","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1200\/JCO.2010.31.6208","volume":"29","author":"L Gandhi","year":"2011","unstructured":"L. Gandhi, D.R. Camidge, M. Ribeiro de Oliveira, P. Bonomi, D. Gandara, D. Khaira et al., Phase I study of navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors. J. Clin. Oncol. 29(7), 909\u2013916 (2011)","journal-title":"J. Clin. Oncol."}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01126-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-025-01126-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01126-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T10:04:52Z","timestamp":1765447492000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-025-01126-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":86,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1126"],"URL":"https:\/\/doi.org\/10.1007\/s13402-025-01126-w","relation":{},"ISSN":["2211-3436"],"issn-type":[{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"4 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study for mice is compliant with all relevant ethical regulations for animal experiments. All experiments and facilities were approved by the Committee for Ethics of Animal Experiments and were conducted in conformity to the Guidelines for Animal Experiments, Shanghai Tenth People\u2019s Hospital, Tongji University School of Medicine (Shanghai, China), the ID Number was SHDSYY-2024-T0577. The study utilized tumors and matched non-malignant tissues sourced from Shanghai East Hospital, Tongji University School of Medicine, China, with approval from the Ethics Committee of Shanghai East Hospital. All patients provided full consent for the study (Approval number: 2024YS-082).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have consented to the publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}